Literature DB >> 22661056

Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT, endoscopic retrograde cholangiography and MR cholangiography.

Jin Hee Kim1, Jae Ho Byun, So Jung Lee, Seong Ho Park, Hyoung Jung Kim, Seung Soo Lee, Myung-Hwan Kim, Jihun Kim, Moon-Gyu Lee.   

Abstract

OBJECTIVES: To compare findings at dynamic computed tomography (CT), endoscopic retrograde cholangiography (ERC) and magnetic resonance cholangiography (MRC) in patients with sclerosing cholangitis with autoimmune pancreatitis (SC-AIP) and periductal infiltrating cancer in the common bile duct (CBD), and to evaluate the diagnostic performance of ERC and MRC in differentiating between the two diseases.
METHODS: Bile duct changes at dynamic CT, ERC and MRC were compared in 58 patients with SC-AIP and CBD involvement and 93 patients with periductal infiltrating CBD cancer. Two radiologists rated their confidence in differentiating between the two diseases and the diagnostic performances of ERC and MRC were compared.
RESULTS: At CT, SC-AIP was more frequently associated with intrapancreatic CBD involvement, thinner CBD walls, concentric wall thickening, smooth outer margins, and lower degrees of upstream ductal dilatation and contrast enhancement (P ≤ 0.05) than CBD cancer. At ERC and MRC, SC-AIP was more frequently associated with smooth margins, gradual and symmetric narrowing, multifocal involvement and hourglass appearance (P ≤ 0.027) than CBD cancer. MRC showed good diagnostic performance comparable to ERC.
CONCLUSIONS: Dynamic CT, ERC and MRC can be helpful in distinguishing SC-AIP from periductal infiltrating CBD cancer. MRC may be a useful diagnostic alternative to ERC in differentiating between the two diseases. KEY POINTS : • SC-AIP often mimics periductal infiltrating ductal cancer. • Imaging findings of SC-AIP and periductal infiltrating CBD cancer can be similar. • Dynamic CT, ERC and MRC help differentiate between these two diseases. • MRC may be a useful diagnostic alternative to ERC.

Entities:  

Mesh:

Year:  2012        PMID: 22661056     DOI: 10.1007/s00330-012-2507-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  33 in total

1.  Extrapancreatic lesions in autoimmune pancreatitis.

Authors:  Terumi Kamisawa; Naoto Egawa; Hitoshi Nakajima; Kouji Tsuruta; Atsutake Okamoto
Journal:  J Clin Gastroenterol       Date:  2005 Nov-Dec       Impact factor: 3.062

2.  Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis?

Authors:  Hideaki Hamano; Shigeyuki Kawa; Takeshi Uehara; Yasuhide Ochi; Mari Takayama; Kenichi Komatsu; Takashi Muraki; Jun Umino; Kendo Kiyosawa; Shinichi Miyagawa
Journal:  Gastrointest Endosc       Date:  2005-07       Impact factor: 9.427

3.  Tumor vessel: a valuable cholangioscopic clue of malignant biliary stricture.

Authors:  H J Kim; M H Kim; S K Lee; K S Yoo; D W Seo; Y I Min
Journal:  Gastrointest Endosc       Date:  2000-11       Impact factor: 9.427

4.  Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Hirotaka Ohara; Hitoshi Sano; Shigeru Aoki; Shinya Kobayashi; Tetsu Okamoto; Hideto Imai; Tomoyuki Nomura; Takashi Joh; Makoto Itoh
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

5.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Yasunori Sato; Koichi Tsuneyama; Joji Haratake; Hiroshi Kurumaya; Kazuyoshi Katayanagi; Shinji Masuda; Hideki Niwa; Hideo Morimoto; Atsuo Miwa; Akio Uchiyama; Bernard C Portmann; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

6.  Autoimmune pancreatitis: imaging features.

Authors:  Dushyant V Sahani; Sanjeeva P Kalva; James Farrell; Michael M Maher; Sanjay Saini; Peter R Mueller; Gregory Y Lauwers; Carlos D Fernandez; Andrew L Warshaw; Joseph F Simeone
Journal:  Radiology       Date:  2004-09-30       Impact factor: 11.105

Review 7.  Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis.

Authors:  Makoto Otsuki; Jae Bock Chung; Kazuichi Okazaki; Myung-Hwan Kim; Terumi Kamisawa; Shigeyuki Kawa; Seung Woo Park; Tooru Shimosegawa; Kyutaek Lee; Tetsuhide Ito; Isao Nishimori; Kenji Notohara; Satoru Naruse; Shigeru B H Ko; Yasuyuki Kihara
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

8.  Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis.

Authors:  Yasunari Fujinaga; Masumi Kadoya; Shigeyuki Kawa; Hideaki Hamano; Kazuhiko Ueda; Mitsuhiro Momose; Satoshi Kawakami; Sachie Yamazaki; Tomoko Hatta; Yukiko Sugiyama
Journal:  Eur J Radiol       Date:  2009-07-05       Impact factor: 3.528

9.  Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes.

Authors:  Na Ra Kim; Jeong Min Lee; Se Hyung Kim; Su Kyung An; Chang Jin Han; Seung Hong Choi; Joon Koo Han; Hye Seung Lee; Ja Jun Jang; Byung Ihn Choi
Journal:  Clin Imaging       Date:  2008 Mar-Apr       Impact factor: 1.605

Review 10.  Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria.

Authors:  Suresh T Chari
Journal:  J Gastroenterol       Date:  2007-05       Impact factor: 7.527

View more
  5 in total

1.  Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors.

Authors:  Myung-Won You; Jin Hee Kim; Jae Ho Byun; Hyoung Jung Kim; Seung Soo Lee; Myung-Hwan Kim; Moon-Gyu Lee
Journal:  Eur Radiol       Date:  2014-02-28       Impact factor: 5.315

Review 2.  Early detection of intrahepatic cholangiocarcinoma.

Authors:  Mami Hamaoka; Kazuto Kozaka; Osamu Matsui; Takahiro Komori; Takashi Matsubara; Norihide Yoneda; Kotaro Yoshida; Dai Inoue; Azusa Kitao; Wataru Koda; Toshifumi Gabata; Satoshi Kobayashi
Journal:  Jpn J Radiol       Date:  2019-08-01       Impact factor: 2.374

Review 3.  Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis.

Authors:  Nieun Seo; So Yeon Kim; Seung Soo Lee; Jae Ho Byun; Jin Hee Kim; Hyoung Jung Kim; Moon-Gyu Lee
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

4.  Immunoglobulin G4 Sclerosing Cholangitis: An Unusual Cause of Obstructive Jaundice-Case Report and Literature Review.

Authors:  Pragya Shrestha; Brian Le; Brent Wagner; William Pompella; Paras Karmacharya
Journal:  Case Rep Rheumatol       Date:  2018-08-23

5.  Differences in Clinical Features and Diagnostic Strategies Between IgG4-Related Autoimmune Cholangitis and Cholangiocarcinoma.

Authors:  Ke Zhu; Jin Yang; Ying-Zhen Chen; Xue-Rong Zhang; Xian-Huan Yu; Jie Wang; Rui Zhang; Chao Liu
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.